UnitedHealth Group Incorporated (NYSE:UNH) released its quarterly earnings results on Tuesday. The healthcare conglomerate reported $2.66 EPS for the quarter, topping the Zacks’ consensus estimate of $2.57 by $0.09, Bloomberg Earnings reports. The company had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. UnitedHealth Group’s revenue was up 8.7% compared to the same quarter last year. During the same quarter last year, the firm posted $2.17 earnings per share. UnitedHealth Group updated its FY17 guidance to $10.00 EPS.

Shares of UnitedHealth Group (UNH) opened at 193.20 on Tuesday. UnitedHealth Group has a 1-year low of $133.03 and a 1-year high of $200.76. The company has a market capitalization of $186.80 billion, a P/E ratio of 23.21 and a beta of 0.63. The company has a 50-day moving average price of $196.56 and a 200 day moving average price of $184.87.

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 19th. Investors of record on Friday, September 8th were paid a $0.75 dividend. The ex-dividend date was Thursday, September 7th. This represents a $3.00 annualized dividend and a yield of 1.55%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.13%.

In other news, Director Gail R. Wilensky sold 5,600 shares of the firm’s stock in a transaction on Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total value of $1,117,144.00. Following the completion of the transaction, the director now directly owns 60,834 shares of the company’s stock, valued at $12,135,774.66. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Richard T. Burke sold 15,000 shares of the firm’s stock in a transaction on Monday, August 21st. The stock was sold at an average price of $191.71, for a total value of $2,875,650.00. Following the completion of the transaction, the director now directly owns 1,818,898 shares of the company’s stock, valued at $348,700,935.58. The disclosure for this sale can be found here. Over the last three months, insiders have sold 76,174 shares of company stock valued at $14,981,909. 0.89% of the stock is owned by corporate insiders.

Several institutional investors have recently bought and sold shares of the company. Regal Wealth Group Inc. boosted its holdings in shares of UnitedHealth Group by 0.4% in the second quarter. Regal Wealth Group Inc. now owns 746 shares of the healthcare conglomerate’s stock worth $138,000 after acquiring an additional 3 shares during the period. Jackson Grant Investment Advisers Inc. boosted its holdings in shares of UnitedHealth Group by 0.4% in the first quarter. Jackson Grant Investment Advisers Inc. now owns 1,097 shares of the healthcare conglomerate’s stock worth $180,000 after acquiring an additional 4 shares during the period. RB Capital Management LLC boosted its holdings in shares of UnitedHealth Group by 0.4% in the second quarter. RB Capital Management LLC now owns 1,732 shares of the healthcare conglomerate’s stock worth $321,000 after acquiring an additional 7 shares during the period. Altfest L J & Co. Inc. boosted its holdings in shares of UnitedHealth Group by 0.3% in the second quarter. Altfest L J & Co. Inc. now owns 2,963 shares of the healthcare conglomerate’s stock worth $549,000 after acquiring an additional 10 shares during the period. Finally, Parkside Financial Bank & Trust boosted its holdings in shares of UnitedHealth Group by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock worth $140,000 after acquiring an additional 12 shares during the period. 86.11% of the stock is owned by hedge funds and other institutional investors.

A number of research firms have recently commented on UNH. BMO Capital Markets began coverage on UnitedHealth Group in a research report on Monday. They set an “outperform” rating and a $250.00 price target on the stock. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $190.00 price target on shares of UnitedHealth Group in a research report on Monday, July 10th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $205.00 price target on shares of UnitedHealth Group in a research report on Friday, July 7th. Credit Suisse Group reaffirmed an “outperform” rating and set a $200.00 price target (up previously from $195.00) on shares of UnitedHealth Group in a research report on Thursday, July 13th. Finally, Citigroup Inc. raised their price target on UnitedHealth Group from $195.00 to $213.00 and gave the stock a “buy” rating in a research report on Wednesday, July 19th. Three research analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the company’s stock. UnitedHealth Group currently has a consensus rating of “Buy” and a consensus target price of $205.94.

ILLEGAL ACTIVITY WARNING: “UnitedHealth Group Incorporated (UNH) Releases Earnings Results, Beats Expectations By $0.09 EPS” was originally published by Daily Political and is the property of of Daily Political. If you are reading this piece on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this piece can be read at https://www.dailypolitical.com/2017/10/17/unitedhealth-group-incorporated-unh-releases-earnings-results-beats-expectations-by-0-09-eps.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Earnings History for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.